Saxenda is a brand name for the medication liraglutide. It is an injectable prescription medication used for weight management in adults who have obesity or who are overweight with at least one weight-related medical condition (e.g., high blood pressure, type 2 diabetes, or high cholesterol).
Liraglutide, the active ingredient in Saxenda, belongs to a class of drugs known as GLP-1 receptor agonists. It mimics the action of a hormone called glucagon-like peptide-1 (GLP-1), which helps regulate blood sugar levels and promotes feelings of fullness after eating. By activating GLP-1 receptors in the brain, Saxenda can help reduce appetite, increase satiety (feeling full), and, as a result, assist with weight loss.
Saxenda is intended to be used as part of a comprehensive weight management plan, which includes a reduced-calorie diet, increased physical activity, and behavior modifications. It is typically administered by self-injection once daily.
It’s essential to note that Saxenda is not a cosmetic weight loss treatment or a standalone solution for weight management. It is specifically designed for people with a body mass index (BMI) that indicates obesity or overweight with related health conditions.
As with any medication, Saxenda may have side effects, and its use should be discussed with a healthcare provider. Common side effects may include nausea, vomiting, diarrhea, and constipation. In some cases, Saxenda can also lead to more severe side effects, such as pancreatitis or gallbladder problems.
If you are considering Saxenda as a weight management option, it’s crucial to consult with a healthcare professional to determine if it is suitable for you, to understand potential risks, and to develop a personalized weight loss plan that meets your specific needs and health goals.
I can offer some general factors that may contribute to not losing weight while using Saxenda:
If you are not experiencing the desired weight loss results with Saxenda, it’s essential to discuss your concerns with your healthcare provider. They can evaluate your individual situation, consider any contributing factors, and help tailor a comprehensive weight loss plan that suits your needs. It’s also crucial to be patient and consistent in your weight loss journey and work closely with your healthcare team for guidance and support.
Descartes Systems (Descartes Systems Stock Quote, Chart, News, Analysts, Financials TSXV:DSG) shares are down about 17% year to date and… [Read More]
Following the company's first quarter results, RBC analyst Paul Treiber has raised his price target on BlackBerry (BlackBerry Stock Quote,… [Read More]
Stifel analyst Justin Keywood has maintained a “Buy” rating on WELL Health Technologies (WELL Health Technologies Stock Quote, Chart, News,… [Read More]
Roth Capital Markets analyst Eric Handler upgraded Electronic Arts (Electronic Arts Stock Quote, Chart, News, Analysts, Financials NASDAQ:EA) to “Buy”… [Read More]
Ventum Capital Markets analyst Amr Ezzat maintained his “Buy” rating and C$52.00 price target on Tecsys (Tecsys Stock Quote, Chart,… [Read More]
Roth Capital Markets analyst Rohit Kulkarni maintained a “Neutral” rating and US$16.00 price target on Lyft (Lyft Stock Quote, Chart,… [Read More]